PC

Pierre Casellas

SA Sanofi-Aventis: 24 patents #6 of 563Top 2%
SA Sanofi: 18 patents #33 of 1,881Top 2%
SA Sanofi-Synthelabo: 6 patents #12 of 327Top 4%
BS Bertrand Faure Equipment Sa: 2 patents #16 of 87Top 20%
📍 Montpellier, FR: #4 of 932 inventorsTop 1%
Overall (All Time): #54,806 of 4,157,543Top 2%
50
Patents All Time

Issued Patents All Time

Showing 26–50 of 50 patents

Patent #TitleCo-InventorsDate
6967203 Use of pyridoindolone derivatives for preparing anticancer medicines Bernard Bourrie, Jean-Marie Derocq 2005-11-22
6767533 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress Jean-Marie Derocq 2004-07-27
6689797 Tetrahydropyridines, preparation method and pharmaceutical compositions containing same Marco Baroni, Bernard Bourrie, Rosanna Cardamone 2004-02-10
6642258 Use of central cannabinoid receptor antagonist for preparing medicines Bernard Bourrie 2003-11-04
6509351 Phenyl- and pyridyl-tetrahydro-pyridines having TNF inhibiting activity Marco Baroni, Bernard Bourrie, Rosanna Cardamone, Umberto Guzzi 2003-01-21
6482986 Benzene derivatives, preparation method and pharmaceutical compositions containing same Robert Boigegrain, Bernard Bourrie, Martine Bourrie, Jean-Marc Herbert, Pierre Lair +3 more 2002-11-19
6344464 Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination Bernard Bourrie, Jean-Pierre Maffrand 2002-02-05
6257541 Slide for vehicle seat, and seat including such slide Michel Timon 2001-07-10
6126133 Slide rail for vehicle seat and seat comprising such a slide rail Michel Timon 2000-10-03
6013648 CB.sub.2 Receptor agonist compounds Murielle Rinaldi, Francis Barth, Christian Congy, Didier Oustric, Malcolm R. Bell +2 more 2000-01-11
5925768 3-pyrazolecarboxamide derivatives having cannabinoid receptor affinity Francis Barth, Joseph Millan, Didier Oustric, Murielle Rinaldi, Martine Sarran 1999-07-20
5624941 Pyrazole derivatives, method of preparing them and pharmaceutical compositions in which they are present Francis Barth, Christian Congy, Serge Martinez, Murielle Rinaldi, Gilles Anne-Archard 1997-04-29
5462960 Pyrazole-3-carboxamide derivatives, process for their preparation and pharmaceutical compositions in which they are present Francis Barth, Christian Congy, Serge Martinez, Murielle Rinaldi 1995-10-31
5449693 Benzene derivatives, their preparation and pharmaceutical compositions in which they are present Jean-Claude Breliere, Serge Lavastre, Raymond Paul 1995-09-12
5354781 Benzene derivatives, their preparation and pharmaceutical compositions in which they are present Jean-Claude Breliere, Serge Lavastre, Raymond Paul 1994-10-11
5162502 Modified trichokirin and their preparation for use in conjugates as inhibitors of protein synthesis Luigi Barbieri, Fiorenzo Stirpe 1992-11-10
5106956 Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and reduction, and in vivo prolonged-action immunotoxins containing such a glycoprotein Bernard Bourrie, Xavier Canat 1992-04-21
5104976 Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a Schiff's base and in-vivo prolonged action immunotoxins containing such a glycoprotein Bernard Bourrie, Xavier Canat 1992-04-14
5037960 Inhibitor of protein synthesis, process for its isolation, its use and pharmaceutical compositions in which it is present Luigi Barbieri, Fiorenzo Stirpe 1991-08-06
4981953 Immunotoxins, process for their preparation and pharmaceutical compositions in which they are present Luigi Barbieri, Fiorenzo Stirpe 1991-01-01
4919927 Process for the potentiation of immunotoxins Pierre Gros, Franz Jansen 1990-04-24
4911911 Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff's base and in-vivo prolonged action immunotoxins containing such a glycoprotein Bernard Bourrie, Xavier Canat 1990-03-27
4911912 Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and reduction, and in vivo prolonged-action immunotoxins containing such a glycoprotein Bernard Bourrie, Xavier Canat 1990-03-27
4749566 Pharmaceutical composition comprising a combination of at least one immunotoxin and at least one mannose-containing polymer Bernard Bourrie, Pierre Gros 1988-06-07
4643895 Anti-cancer drugs for the treatment of leukaemias I, constituted by the chain A of ricin and a specific monoclanal antibody Pierre Gros, Franz Jansen 1987-02-17